Grupo-Publicaciones-GIIS077

Santaliestra M, Garrote M, Noya M, Pérez-Encinas M, Senín A, Pérez-López R, Ferrer-Marín F, Carreño-Tarragona G, Caballero Navarro G, Magro E, Vélez P, Cortés Vázquez M, Moretó A, Angona A, Pastor-Galán I, Guerra J, García Hernández C, Mata M, Stuckey R, Gómez-Casares M, Fox L, Cuevas B, García-Gutiérrez V, Triguero A, Arellano-Rodrigo E, Hernández-Boluda J, Alvarez-Larrán A. Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia.. Leukemia. 2024. 10.1038/s41375-024-02416-2. FI-12,8

Crisà E, Mora E, Germing U, Bally C, Diez Campelo M, Myllymäki M, Jädersten M, Komrokji R, Platzbecker U, Haase D, Hofmann W, Al Ali N, Barraco D, Bargay J, Bernal T, López Cadenas F, Calvisi A, Capodanno I, Cerrano M, Ciancia R, Crugnola M, Kündgen A, Finelli C, Fozza C, Frairia C, Freja E, Ganster C, Kubasch A, Jimenez M, Latagliata R, Hernandez Mohedo F, Molero A, Vara Pampliega M, Perez C, Pietrantuono G, Poloni A, Pomares H, Recasens Flores M, Rüfer A, Signori A, Hellstrom-Lindberg E, Fenaux P, Sanz G, Santini V. Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study.. Leukemia. 2024. 10.1038/s41375-024-02360-1. FI-12,8

Pascual-Izquierdo C, Sánchez-González B, Canaro-Hirnyk M, García-Donas G, Menor-Gómez M, Gil-Fernández J, Monsalvo-Saornil S, de-Laiglesia A, Álvarez-Román M, Jarque-Ramos I, Llácer M, Pedrote-Amador B, Zafra-Torres D, Caparrós-Miranda I, Ortúzar-Pasalodos A, Revilla-Calvo N, Bastida J, Chica-Gullón E, Alvarellos M, Jiménez-Bárcenas R, Bernat S, Martínez-Carballeira D, Lakhwani S, López-Ansoar E, Moreno-Beltrán M, Lorenzo-Vizcaya Á, Aguirre M, Lasa-Eguialde M, Canet M, González-Gascón-Y-Marín I, Caballero Navarro G, Cuesta A, Díaz-López M, Arquero T, Moreno-Carbonell M, Mingot-Castellano M, Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy . Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).. AMERICAN JOURNAL OF HEMATOLOGY. 2024. 10.1002/ajh.27498. FI-10,1

Pérez Carretero C, González T, Quijada Álamo M, Rigolin G, Dubuc A, Villaverde Ramiro Á, Rodríguez-Sánchez A, Rubio Martínez A, Dávila J, Vidal M, González Gascón Y Marín I, Hernández-Rivas J, Benito R, Volpe V, Davids M, Abramson J, Cuneo A, Dal Cin P, Rodríguez-Vicente A, Hernández-Rivas J. Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.. AMERICAN JOURNAL OF HEMATOLOGY. 2024. 10.1002/ajh.27421. FI-10,1

Martínez-Cuadrón D, Megías-Vericat J, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Serrano J, Herrera P, Simón J, Sayas M, Bergua J, Lavilla-Rubira E, Amigo M, Benavente C, Lorenzo J, Pérez-Encinas M, Vidriales M, Colorado M, de Rueda Ciller B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero M, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.. HAEMATOLOGICA. 2024. 10.3324/haematol.2022.282506. FI-8,2

Alvarez-Larran A, Garrote M, Ferrer-Marin F, Perez-Encinas M, Mata-Vazquez M, Bellosillo B, Arellano-Rodrigo E, Gomez M, Garcia R, Garcia-Gutierrez V, Gasior M, Cuevas B, Angona A, Gomez-Casares M, Martinez C, Magro E, Ayala R, del Orbe-Barreto R, Perez-Lopez R, Fox M, Raya J, Guerrero L, Garcia-Hernandez C, Caballero Navarro G, Murillo Flórez I, Xicoy B, Ramirez M, Carreno-Tarragona G, Hernandez-Boluda J, Pereira A, MPN Spanish Grp , Grupo Espanol Enfermedades Mielopr . Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea. CANCER. 2022. 10.1002/cncr.34195. FI-6,1

Zamora-Cánovas A, de la Morena-Barrio B, Marín-Quilez A, Sierra-Aisa C, Male C, Fernández Mosteirin N, Trapero-Marugán M, Padilla J, Garrido-Rodriguez P, Sánchez-Fuentes A, Rodríguez-Alen A, Gómez-González P, Revilla N, de la Morena-Barrio M, Bastida J, Corral J, Rivera J, Lozano M. Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders.. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2024. 10.1016/j.jtha.2023.11.007. FI-5,5

Abadía Molina C, Ros N, González Tarancón R, Rello Varas L, Recasens Flores M, Izquierdo Álvarez S. Hereditary hemochromatosis: An update vision of the laboratory diagnosis. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY. 2023. 10.1016/j.jtemb.2023.127194. FI-3,6

Nieto J, Rochas-Lopez S, Gonzalez-Fernandez F, Villegas-Martinez A, Bolan-Calderon E, Salido-Fierrez E, Cela E, Huerta-Aragoneses J, Ordon-Garcia M, Muruzabal-Sitges M, Abio-Calvete M, Navarro J, de la Iglesia S, Morado M, San Roman-Pacheco S, Martin-Mateos M, Recasens Flores M, Benavente-Cuesta C, Ropero-Gradilla P, Erithropatology Working Grp . Next generation sequencing for diagnosis of hereditary anemia: Experience in a Spanish reference center. CLINICA CHIMICA ACTA. 2022. 10.1016/j.cca.2022.03.024. FI-3,2

Marco Sánchez J, Bardón Cancho E, Benéitez D, Payán-Pernía S, Collado Gimbert A, Ruiz-Llobet A, Salinas J, Sebastián E, Argilés B, Bermúdez M, Vázquez M, Ortega M, López Rubio M, Gondra A, Uriz J, Morado M, Coll M, López Duarte M, Baro M, Cervera Á, Recasens Flores M, García Blanes C, Del Carcavilla M, Tallon M, González Espín A, Olteanu Olteanu F, González P, Del Mañú Pereira M, Cela E. Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR).. ANNALS OF HEMATOLOGY. 2024. 10.1007/s00277-024-05788-8. FI-3